Modulation of complement-mediated immune damage by intravenous immune globulin

Clinical and Experimental Immunology, Supplement

Volumn 104, Issue SUPPL. 1, 1996, Pages 21-25

  Basta, M ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Complement; Immune globulin therapy; Immunomodulation

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; FORSSMAN ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN M;

ANIMAL EXPERIMENT; CLEARANCE; COMPLEMENT ACTIVATION; CONFERENCE PAPER; CONTROLLED STUDY; ERYTHROCYTE; GUINEA PIG; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SHOCK;

ADJUVANTS, IMMUNOLOGIC; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANIMALS; AUTOIMMUNE DISEASES; COMPLEMENT SYSTEM PROTEINS; DERMATOMYOSITIS; ERYTHROCYTES; FORSSMAN ANTIGEN; GUINEA PIGS; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS;

EID: 0029998794     PISSN: 09642536     EISSN: None     Source Type: Journal    
DOI: 10.1111/cei.1996.104.s1.21     Document Type: Article

References (19)

1. Kurlander RJ, Ellison DM, Hall J. The blockade of Fc receptor-mediated clearance of immune complexes in vivo by monoclonal antibody (2.4G2) directed against Fc receptors on murine leukocytes. J Immunol 1984; 133:855-62.
2. Fehr J, Hofmann V, Kapeller U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma-globulin. N Engl J Med 1982; 306:1254-8.
3. Rossi, F, Sultan Y, Kazatchkine MD. Spontaneous and therapeutic suppression of autoimmune response to factor VIII by anti-idiotyopic antibodies. In: Morell A, Nydegger UE, eds. Clinical Use of Intravenous Immunoglobulins. London: Academic Press, 1986 pp 421-30.
4. Durandy A, Fisher A, Griscelli C. Dysfunctions of pokeweed mitogen-stimulated T and B lymphocyte responses induced by gammaglobulin therapy. J Clin Invest 1981; 67:867-77.
5. Dammacco F, Iodice G, Campobasso N. Treatment of adult patients with idiopathic thrombocytopenic purpura with intravenous immunoglobulin: effect on circulating T-cell subsets and PWM-induced antibody synthesis in vitro. Br J Haematol 1986; 62:125-35.
6. Leung DY, Burns JC, Newburger JW, Geha RS. Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin. J Clin Invest 1987; 79:468-72.
7. Andersson JP, Andersson UG. Human intravenous immunoglobulin modulates monokine production in vitro. Immunology 1990; 71:372-6.
8. Blasczyk R, Westhoff U, Grosse-Wilde H. Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations. Lancet 1993; 341:789-90.
9. Frank MM. Pathophysiology of immune hemolytic anemia. Ann Intern Med 1977; 87:210-22.
10. May JE, Frank MM. Complement-mediated tissue damage: Contribution of the classical and alternate complement pathways in the Forssman reaction. J Immunol 1972; 108:1517-25.
11. Basta M, Langlois PF, Marques M, Frank MM. High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance. Blood 1989; 74:326-33.
12. Basta M, Fries LF, Frank MM. High doses of intravenous Ig inhibit in vitro uptake of C4 fragments onto sensitized eythrocytes. Blood 1991; 77:376-80.
13. Basta M, Kirshbom P, Frank MM, Fries LF. Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. J Clin Invest 1989; 84:1974-81.
14. Humphrey JH, Dourmashkin RR. Electron microscope studies of immune cell lysis. In: Wolstenholme GEW, Knight J, eds. Complement. Ciba Foundation Symposium. Boston: Little Brown & Co, 1965:175-9.
15. Basta M, Dalakas MC. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J Clin Invest 1994; 94:1729-35.
16. Vakeva A, Laurila P, Meri S. Regulation of membrane attack complex formation in myocardial infarction. Am J Pathol 1993; 143:65-75.
17. Mackler BF, Altman LC, Rosenstreich DL, Oppenheim JJ. Induction of lymphokine production by EAC and of blastogenesis by soluble mitogens during human B-cell activity. Nature 1974; 249:834-7.
18. Shearer WT, Atkinson JP, Frank MM, Parker CW. Humoral immunostimulation. IV. Role of complement. J Exp Med 1975; 141(4):736-52.
19. Newburger JW, Takahashi M, Beiser AS et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991; 324(23):1633-9.